简介:
Overview
This study presents a standardized mouse model for subarachnoid hemorrhage (SAH) through double injections of autologous blood into the cisterna magna. The protocol aims to simulate the physiological conditions of SAH with enhanced control over hemorrhage and reduced mortality risk.
Key Study Components
Area of Science
- Neuroscience
- Experimental Therapeutics
- Animal Models
Background
- Subarachnoid hemorrhage is often caused by aneurysm rupture.
- Mortality rates for SAH can be high, with survivors experiencing significant cognitive deficits.
- Current therapies are inefficient, highlighting the need for improved understanding and models.
- Animal models are essential for studying the pathophysiology and testing new treatments.
Purpose of Study
- To describe a reliable mouse model for SAH using double blood injections.
- To enhance the reproducibility of the surgical procedure and control over blood distribution.
- To facilitate the exploration of therapeutic targets during SAH research.
Methods Used
- The procedure involves a surgical model using mouse subjects.
- Specifically, the model comprises two consecutive blood injections into the cisterna magna.
- The methodology ensures minimal increase in intracranial pressure during the injections.
- The protocol includes specific anesthetic and surgical techniques to safely administer blood while minimizing complications.
Main Results
- The model showcases the ability to effectively induce SAH while maintaining low mortality rates.
- Critical steps outlined in the methodology ensure consistent execution of the procedure.
- Data regarding physiological responses post-injection can inform future therapeutic interventions.
- The findings underscore the advantages of using this model in exploring SAH-related pathophysiology.
Conclusions
- This study establishes a valuable experimental model for investigating subarachnoid hemorrhage.
- The protocol can lead to enhanced understanding of SAH and its treatment options.
- Potential implications include identifying new therapeutic approaches and insights into neuronal adaptations following SAH.
What are the advantages of the standardized mouse model for SAH?
The model allows for consistent reproduction of SAH pathology, minimizes variations in hemorrhage control, and reduces mortality risk, making it beneficial for therapeutic studies.
How is the blood injection procedure implemented in the model?
The procedure involves isolating the carotid artery to obtain blood, followed by sequential injections into the cisterna magna while monitoring the animal's vital signs closely.
What types of outcomes can be obtained from this SAH model?
The model enables assessment of physiological responses, potential cognitive deficits, and responses to various therapeutic interventions after SAH induction.
How can the protocol be adapted for different experimental needs?
Researchers can modify the volume and rate of blood injections, as well as use different surgical techniques to tailor the model based on specific research aims.
What are some considerations or limitations associated with this model?
While effective, the model requires skilled surgical techniques, and variations in mouse strain or handling may affect results, necessitating careful planning and standardization.